IBM entered a multiyear strategic partnership with Beijing, China-based Baheal Pharmaceutical Group.
Baheal — which works with more than 12,000 hospitals across China — will implement Watson for Oncology in multiple facilities. The group has already instituted the technology at Qingdao University Affiliate Hospital and Qingdao City Hospital, impacting more than 350 patients to date.
"Watson for Oncology will complement the robust digital health program that Baheal has already implemented," said Gang Fu, chairman of Baheal. "Oncologists in China have very little time to spend with each of their patients, and by deploying Watson for Oncology across our network, we aim to give our doctors more time to focus on the best decisions they can make for their patients."